Virologic response to first-line efavirenz- or nevirapine-based antiretroviral therapy in HIV-infected African children (Pediatric Infectious Disease Journal, 2017)

(untitled) - Kekitiinwa, A; Szubert, A; Spyer, M; Katuramu, R; Musiime, V; Mhute, T; Bakeera-Kitaka, S; Senfuma, O; Walker, A; Gibb, D; ARROW Trial Team,